Abcellera Current Deferred Revenue vs Short Term Investments Analysis

ABCL Stock

USD 3.64 0.14 3.70%

Abcellera BiologicsInc financial indicator trend analysis is way more than just evaluating Abcellera BiologicsInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abcellera BiologicsInc is a good investment. Please check the relationship between Abcellera BiologicsInc Current Deferred Revenue and its Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.

Current Deferred Revenue vs Short Term Investments

Current Deferred Revenue vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abcellera BiologicsInc Current Deferred Revenue account and Short Term Investments. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Abcellera BiologicsInc's Current Deferred Revenue and Short Term Investments is -0.15. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Abcellera BiologicsInc, assuming nothing else is changed. The correlation between historical values of Abcellera BiologicsInc's Current Deferred Revenue and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Abcellera BiologicsInc are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Current Deferred Revenue i.e., Abcellera BiologicsInc's Current Deferred Revenue and Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.15

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Short Term Investments

Short Term Investments is an item under the current assets section of Abcellera BiologicsInc balance sheet. It contains any investments Abcellera BiologicsInc undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Abcellera BiologicsInc can easily liquidate in the marketplace.

Most indicators from Abcellera BiologicsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abcellera BiologicsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.At this time, Abcellera BiologicsInc's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 1.68 this year, although the value of Tax Provision is projected to rise to (26.2 M).

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.8M	59.7M	30.9M	20.4M
Interest Income	3.3M	16.1M	42.2M	44.4M

Depreciation And Amortization Interest Income

Abcellera BiologicsInc fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		0.89	0.95	0.99	1.0	0.98	0.95	0.83	0.82	-0.69	0.96	0.99	0.79	0.97	0.96	1.0	0.71	0.99	0.83	0.98	0.79	0.78	0.99	1.0	0.82	-0.97
Short Long Term Debt Total	0.89		0.7	0.83	0.88	0.87	0.87	0.89	0.89	-0.33	0.95	0.86	0.46	0.96	0.81	0.87	0.3	0.82	0.71	0.94	0.87	0.85	0.91	0.88	0.89	-0.79
Other Current Liab	0.95	0.7		0.98	0.95	0.93	0.9	0.68	0.69	-0.84	0.85	0.95	0.9	0.86	0.95	0.96	0.89	0.98	0.79	0.88	0.62	0.64	0.93	0.96	0.68	-0.98
Total Current Liabilities	0.99	0.83	0.98		0.99	0.98	0.94	0.78	0.78	-0.75	0.93	0.99	0.84	0.94	0.97	0.99	0.79	0.99	0.82	0.95	0.73	0.74	0.98	0.99	0.78	-0.99
Total Stockholder Equity	1.0	0.88	0.95	0.99		0.98	0.95	0.82	0.82	-0.7	0.96	0.99	0.8	0.97	0.96	1.0	0.71	0.99	0.83	0.97	0.79	0.77	0.99	1.0	0.82	-0.98
Other Liab	0.98	0.87	0.93	0.98	0.98		0.92	0.8	0.77	-0.66	0.94	0.98	0.75	0.97	0.95	0.97	0.69	0.97	0.83	0.98	0.73	0.75	0.99	0.98	0.79	-0.94
Net Tangible Assets	0.95	0.87	0.9	0.94	0.95	0.92		0.93	0.93	-0.54	0.91	0.93	0.65	0.94	0.89	0.95	0.65	0.93	0.79	0.94	0.73	0.91	0.95	0.95	0.93	-0.97
Property Plant And Equipment Net	0.83	0.89	0.68	0.78	0.82	0.8	0.93		0.99	-0.21	0.84	0.79	0.34	0.89	0.73	0.81	0.35	0.76	0.68	0.88	0.71	0.99	0.85	0.82	1.0	-0.81
Current Deferred Revenue	0.82	0.89	0.69	0.78	0.82	0.77	0.93	0.99		-0.23	0.83	0.77	0.36	0.88	0.74	0.81	0.36	0.77	0.65	0.85	0.72	0.99	0.83	0.82	0.99	-0.82
Net Debt	-0.69	-0.33	-0.84	-0.75	-0.7	-0.66	-0.54	-0.21	-0.23		-0.58	-0.73	-0.99	-0.51	-0.73	-0.72	-0.91	-0.75	-0.59	-0.55	-0.44	-0.14	-0.63	-0.7	-0.2	0.74
Retained Earnings	0.96	0.95	0.85	0.93	0.96	0.94	0.91	0.84	0.83	-0.58		0.97	0.69	0.96	0.88	0.96	0.53	0.91	0.82	0.96	0.91	0.78	0.96	0.96	0.83	-0.9
Accounts Payable	0.99	0.86	0.95	0.99	0.99	0.98	0.93	0.79	0.77	-0.73	0.97		0.82	0.94	0.94	0.99	0.72	0.97	0.84	0.96	0.81	0.73	0.98	0.99	0.78	-0.96
Cash	0.79	0.46	0.9	0.84	0.8	0.75	0.65	0.34	0.36	-0.99	0.69	0.82		0.62	0.81	0.81	0.91	0.83	0.67	0.66	0.54	0.28	0.74	0.8	0.34	-0.82
Non Current Assets Total	0.97	0.96	0.86	0.94	0.97	0.97	0.94	0.89	0.88	-0.51	0.96	0.94	0.62		0.92	0.96	0.54	0.94	0.79	0.99	0.79	0.85	0.98	0.96	0.89	-0.91
Long Term Debt	0.96	0.81	0.95	0.97	0.96	0.95	0.89	0.73	0.74	-0.73	0.88	0.94	0.81	0.92		0.96	0.76	0.98	0.67	0.93	0.67	0.69	0.95	0.96	0.73	-0.94
Cash And Short Term Investments	1.0	0.87	0.96	0.99	1.0	0.97	0.95	0.81	0.81	-0.72	0.96	0.99	0.81	0.96	0.96		0.72	0.99	0.83	0.96	0.8	0.76	0.99	1.0	0.8	-0.98
Net Receivables	0.71	0.3	0.89	0.79	0.71	0.69	0.65	0.35	0.36	-0.91	0.53	0.72	0.91	0.54	0.76	0.72		0.79	0.59	0.58	0.26	0.32	0.67	0.72	0.35	-0.81
Common Stock Total Equity	0.99	0.82	0.98	0.99	0.99	0.97	0.93	0.76	0.77	-0.75	0.91	0.97	0.83	0.94	0.98	0.99	0.79		0.8	0.95	0.7	0.72	0.98	0.99	0.76	-0.98
Common Stock Shares Outstanding	0.83	0.71	0.79	0.82	0.83	0.83	0.79	0.68	0.65	-0.59	0.82	0.84	0.67	0.79	0.67	0.83	0.59	0.8		0.81	0.68	0.64	0.82	0.82	0.68	-0.8
Non Current Liabilities Total	0.98	0.94	0.88	0.95	0.97	0.98	0.94	0.88	0.85	-0.55	0.96	0.96	0.66	0.99	0.93	0.96	0.58	0.95	0.81		0.78	0.83	0.99	0.97	0.87	-0.92
Other Current Assets	0.79	0.87	0.62	0.73	0.79	0.73	0.73	0.71	0.72	-0.44	0.91	0.81	0.54	0.79	0.67	0.8	0.26	0.7	0.68	0.78		0.63	0.77	0.79	0.7	-0.7
Other Stockholder Equity	0.78	0.85	0.64	0.74	0.77	0.75	0.91	0.99	0.99	-0.14	0.78	0.73	0.28	0.85	0.69	0.76	0.32	0.72	0.64	0.83	0.63		0.8	0.77	0.99	-0.77
Total Liab	0.99	0.91	0.93	0.98	0.99	0.99	0.95	0.85	0.83	-0.63	0.96	0.98	0.74	0.98	0.95	0.99	0.67	0.98	0.82	0.99	0.77	0.8		0.99	0.85	-0.96
Net Invested Capital	1.0	0.88	0.96	0.99	1.0	0.98	0.95	0.82	0.82	-0.7	0.96	0.99	0.8	0.96	0.96	1.0	0.72	0.99	0.82	0.97	0.79	0.77	0.99		0.82	-0.98
Property Plant And Equipment Gross	0.82	0.89	0.68	0.78	0.82	0.79	0.93	1.0	0.99	-0.2	0.83	0.78	0.34	0.89	0.73	0.8	0.35	0.76	0.68	0.87	0.7	0.99	0.85	0.82		-0.81
Short Long Term Debt	-0.97	-0.79	-0.98	-0.99	-0.98	-0.94	-0.97	-0.81	-0.82	0.74	-0.9	-0.96	-0.82	-0.91	-0.94	-0.98	-0.81	-0.98	-0.8	-0.92	-0.7	-0.77	-0.96	-0.98	-0.81

Click cells to compare fundamentals

Abcellera BiologicsInc Account Relationship Matchups

Abcellera BiologicsInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	23.5M	1.0B	1.3B	1.5B	1.5B	989.6M
Short Long Term Debt Total	6.9M	6.1M	36.4M	82.3M	77.4M	39.0M
Other Current Liab	129.3K	76.7M	77.5M	58.0M	61.3M	50.2M
Total Current Liabilities	7.9M	103.5M	120.7M	118.3M	119.0M	87.2M
Total Stockholder Equity	10.3M	830.5M	1.0B	1.2B	1.2B	781.7M
Other Liab	1.3M	65.6M	134.0M	112.6M	129.5M	69.6M
Net Tangible Assets	2.7M	683.9M	829.5M	1.1B	1.2B	1.3B
Property Plant And Equipment Net	8.5M	17.9M	111.6M	217.3M	287.7M	302.1M
Current Deferred Revenue	3.2M	6.6M	7.5M	21.6M	26.1M	27.4M
Net Debt	(661.9K)	(588.0M)	(439.7M)	(304.3M)	(55.9M)	(58.7M)
Retained Earnings	(4.7M)	114.2M	267.7M	426.2M	279.8M	198.1M
Accounts Payable	1.6M	20.0M	32.0M	33.2M	25.5M	20.9M
Cash	7.6M	594.1M	476.1M	386.5M	133.3M	126.7M
Non Current Assets Total	10.8M	192.2M	388.8M	515.4M	616.1M	317.1M
Cash And Short Term Investments	7.6M	594.1M	723.0M	886.5M	760.6M	546.7M
Net Receivables	4.4M	213.2M	160.6M	38.6M	64.4M	89.0M
Common Stock Total Equity	5.1M	710.4M	722.4M	734.4M	844.5M	479.0M
Common Stock Shares Outstanding	154.1M	269.5M	318.3M	314.8M	289.2M	290.3M
Liabilities And Stockholders Equity	23.5M	1.0B	1.3B	1.5B	1.5B	989.6M
Non Current Liabilities Total	5.3M	71.5M	172.2M	189.3M	216.8M	120.7M
Capital Lease Obligations	3.1M	3.7M	36.4M	82.3M	77.4M	81.2M
Other Current Assets	1.8M	6.0M	21.2M	75.4M	20.9M	23.1M
Other Stockholder Equity	2.3M	5.9M	35.4M	74.1M	121.1M	127.1M
Total Liab	13.2M	175.0M	292.8M	307.6M	335.8M	208.0M
Net Invested Capital	6.5M	832.9M	1.0B	1.2B	1.2B	780.7M
Property Plant And Equipment Gross	8.5M	17.9M	121.4M	235.7M	318.3M	334.2M
Total Current Assets	12.6M	813.3M	929.8M	1.0B	872.0M	672.5M
Capital Stock	12.7M	710.4M	722.4M	734.4M	753.2M	540.0M
Net Working Capital	4.7M	709.8M	809.1M	907.2M	753.0M	585.3M
Short Term Debt	2.9M	190K	3.7M	5.6M	6.2M	3.9M
Common Stock	5.1M	710.4M	722.4M	734.4M	753.2M	537.3M
Property Plant Equipment	8.5M	17.9M	111.6M	217.3M	249.8M	262.3M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Abcellera BiologicsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Abcellera BiologicsInc is a strong investment it is important to analyze Abcellera BiologicsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera BiologicsInc's future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:

How To Invest In Abcellera

Details

Is Abcellera Stock a good investment?

Details

What is Abcellera BiologicsInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.

Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Abcellera Stock analysis

When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.

	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Commodity Directory Find actively traded commodities issued by global exchanges
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation

Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.459

Earnings Share

(0.51)

Revenue Per Share

0.131

Quarterly Revenue Growth

(0.57)

Return On Assets

(0.1)

The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abcellera Current Deferred Revenue vs Short Term Investments Analysis

Current Deferred Revenue vs Short Term Investments

Current Deferred Revenue vs Short Term Investments Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Short Term Investments

Abcellera BiologicsInc fundamental ratios Correlations

Abcellera BiologicsInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Abcellera BiologicsInc fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Abcellera Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Cash	- 0.99	Net Debt
Short Long Term Debt	- 0.99	Total Current Liabilities
Short Long Term Debt	- 0.98	Net Invested Capital
Short Long Term Debt	- 0.98	Common Stock Total Equity
Short Long Term Debt	- 0.98	Cash And Short Term Investments
Short Long Term Debt	- 0.98	Total Stockholder Equity